|Articles|July 1, 2003
Outpatient Therapy
Chicago - Outpatient, self-administered chemobiotherapy can be delivered safely and effectively for patients with metastatic melanoma, according to a study presented at the 39th annual meeting of the American Association of Clinical Oncology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Ruxolitinib’s Role in Sustained Vitiligo Management
2
Clinical Tips for Managing Moderate to Severe Psoriasis With Systemics
3
Derm Dispatch at SDPA Fall 2025: Elevating the Next Generation Through the Emerging Scholars Program
4
Cutaneous Clues to Systemic Disease: A Rheumatology Overview for Dermatologists
5
















